Asia Pacific Immunofluorescence Assay Market Size & Outlook

The immunofluorescence assay market in Asia Pacific is expected to reach a projected revenue of US$ 1,085.3 million by 2030. A compound annual growth rate of 5.8% is expected of Asia Pacific immunofluorescence assay market from 2024 to 2030.
Revenue, 2023 (US$M)
$732.5
Forecast, 2030 (US$M)
$1,085.3
CAGR, 2024 - 2030
5.8%
Report Coverage
Asia Pacific

Asia Pacific immunofluorescence assay market, 2018-2030 (US$M)

Asia

Asia Pacific immunofluorescence assay market highlights

  • The Asia Pacific immunofluorescence assay market generated a revenue of USD 732.5 million in 2023.
  • The market is expected to grow at a CAGR of 5.8% from 2024 to 2030.
  • In terms of segment, indirect immunofluorescence was the largest revenue generating type in 2023.
  • Indirect Immunofluorescence is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, China is expected to register the highest CAGR from 2024 to 2030.


Asia Pacific data book summary

Market revenue in 2023USD 732.5 million
Market revenue in 2030USD 1,085.3 million
Growth rate5.8% (CAGR from 2023 to 2030)
Largest segmentIndirect immunofluorescence
Fastest growing segmentIndirect Immunofluorescence
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationIndirect Immunofluorescence, Direct Immunofluorescence
Key market players worldwideThermo Fisher Scientific Inc, Inova Diagnostics, Bio-Rad Laboratories Inc, Abcam PLC, PerkinElmer, Merck KGaA, Cell Signaling Technology, Sino Biological, Danaher Corp


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 21.4% of the global immunofluorescence assay market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,085.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Immunofluorescence Assay Market Companies

Name Profile # Employees HQ Website

Asia Pacific immunofluorescence assay market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunofluorescence assay market will help companies and investors design strategic landscapes.


Indirect immunofluorescence was the largest segment with a revenue share of 64.55% in 2023. Horizon Databook has segmented the Asia Pacific immunofluorescence assay market based on indirect immunofluorescence, direct immunofluorescence covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Asia Pacific immunofluorescence assay market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific immunofluorescence assay market databook

  • Our clientele includes a mix of immunofluorescence assay market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific immunofluorescence assay market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific immunofluorescence assay market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific immunofluorescence assay market report size, by country, 2018-2030 (US$M)

Asia Pacific Immunofluorescence Assay Market Share, 2023 & 2030 (US$M)

Asia Pacific immunofluorescence assay market report size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more